Literature DB >> 20470767

Serum glycated albumin levels, but not glycated hemoglobin, is low in relation to glycemia in non-diabetic men with nonalcoholic fatty liver disease with high alanine aminotransferase levels.

Masafumi Koga1, Jun Murai, Hiroshi Saito, Mikio Mukai, Soji Kasayama.   

Abstract

OBJECTIVES: We have reported that serum glycated albumin (GA) levels are low in obese subjects, smokers and hyperuricemic subjects in whom high sensitive CRP (hs-CRP) is elevated. Because patients with nonalcoholic fatty liver disease with high alanine aminotransferase (ALT) levels are reported to show high levels of hs-CRP, the relationship between serum ALT and serum GA levels was investigated. DESIGN AND METHODS: This study comprised 196 non-diabetic men without drinking habit.
RESULTS: Compared with the normal ALT group (serum ALT < or =30 U/L; n=158), the high ALT group (serum ALT >30 U/L; n=38) had significantly higher fasting plasma glucose (PG), OGTT 2-h PG and HbA(1C) levels. Meanwhile, serum GA was significantly lower, and hs-CRP was significantly higher in the high ALT group.
CONCLUSIONS: The results obtained indicate that serum GA is under a negative control of hs-CRP in subjects with high ALT without drinking habit. 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470767     DOI: 10.1016/j.clinbiochem.2010.05.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

Review 1.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 2.  Glycated albumin: from biochemistry and laboratory medicine to clinical practice.

Authors:  Elena Dozio; Nicola Di Gaetano; Peter Findeisen; Massimiliano Marco Corsi Romanelli
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

Review 3.  Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases.

Authors:  Rosaria Vincenza Giglio; Bruna Lo Sasso; Luisa Agnello; Giulia Bivona; Rosanna Maniscalco; Daniela Ligi; Ferdinando Mannello; Marcello Ciaccio
Journal:  J Clin Med       Date:  2020-11-11       Impact factor: 4.241

4.  Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients.

Authors:  Pil Gyu Park; Jung Yoon Pyo; Sung Soo Ahn; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  BMC Nephrol       Date:  2022-08-18       Impact factor: 2.585

5.  Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.

Authors:  Cyrus V Desouza; Richard G Holcomb; Julio Rosenstock; Juan P Frias; Stanley H Hsia; Eric J Klein; Rong Zhou; Takuji Kohzuma; Vivian A Fonseca
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.